NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/07/2025
Back to search
Official data from USPTO
SUN PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
08/26/2025
Trademark type
Combined
Nice classes
5
Filing date
05/13/2014
Registration date
03/24/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/07/2025
Last transaction
08/26/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
1993-00-00
First use in commerce
1997-00-00
Drawing code
3
Owner type
16
Owner location
Mumbai, IN
Examiner
CANTOR, JILLIAN
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a stylized design of a sun underneath which is the word "SUN" underneath which is the word "PHARMA".
Holders and representatives
Holders
SUN PHARMACEUTICAL INDUSTRIES LIMITED
Representatives
Craig Kuchii Sun Pharmaceutical Industries, Inc.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
House mark for pharmaceuticals
Publications
History of USPTO decisions and trademark events.
31 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/07/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/07/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/07/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
03/21/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/24/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/27/2021
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/27/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/26/2021
E815
TEAS SECTION 8 & 15 RECEIVED
03/23/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
03/24/2015
PUBO
PUBLISHED FOR OPPOSITION
01/06/2015
NPUB
NOTICE OF PUBLICATION
12/17/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/03/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/02/2014
CNEA
EXAMINERS AMENDMENT MAILED
11/26/2014
XAEC
EXAMINER'S AMENDMENT ENTERED
11/25/2014
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/25/2014
CNFR
FINAL REFUSAL MAILED
11/13/2014
CNFR
FINAL REFUSAL WRITTEN
11/12/2014
ACEC
AMENDMENT FROM APPLICANT ENTERED
11/07/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/07/2014
ALIE
ASSIGNED TO LIE
11/05/2014
PAPER RECEIVED
11/03/2014
CEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION MAILED
08/28/2014
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
08/28/2014
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
08/28/2014
DOCK
ASSIGNED TO EXAMINER
08/27/2014
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
05/28/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/27/2014
NWAP
NEW APPLICATION ENTERED
05/16/2014
Continuous trademark protection
Get notified about every new filing that threatens SUN PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.